tiprankstipranks
Trending News
More News >
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
US Market
Advertisement

Day One Biopharmaceuticals (DAWN) Ownership - Who Owns Day One Biopharmaceuticals?

Compare
347 Followers

Day One Biopharmaceuticals (DAWN) Ownership Overview

16.77%21.93%0.14%11.76%49.40%
16.77% Insiders
0.14% Other Institutional Investors
11.76% ETFs
49.40% Public Companies and Individual Investors
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 33.83% of the company’s stock is owned by Institutional Investors, 16.77% is owned by Insiders, and 49.40% is owned by Public Companies and Individual Investors.
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 22.07% of the company’s stock is owned by Institutional Investors, 16.77% is owned by Insiders, and 11.76% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
12,929,322Insider12.76%84,040,593
5,755,577Institution5.68%37,411,251
5,664,601Institution5.59%36,819,907
5,024,867Institution4.96%32,661,636
3,401,826Institution3.36%22,111,869
3,219,302Institution3.18%20,925,463
3,103,448Institution3.06%20,172,412
2,960,740Institution2.92%19,244,810
2,558,563Institution2.52%16,630,660
2,334,142Institution2.30%15,171,923

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
5,024,867Institution4.96%32,661,636
3,219,302Institution3.18%20,925,463
2,334,142Institution2.30%15,171,923
1,812,632Institution1.79%11,782,108
1,453,503Institution1.43%9,447,770
1,395,300Institution1.38%9,069,450
1,372,775Institution1.35%8,923,038
936,000Institution0.92%6,084,000
780,859Institution0.77%5,075,584
607,465Institution0.60%3,948,523

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,439,880Institution2.41%15,859,220
1,759,178Institution1.74%11,434,657
1,147,317Institution1.13%7,595,239
1,078,633Institution1.06%7,011,115
928,400Institution0.92%6,034,600
592,689Institution0.58%3,852,479
585,434Institution0.58%3,805,321
461,186Institution0.45%2,997,709
366,415Institution0.36%2,381,698
320,984Institution0.32%2,124,914

FAQ

Who Owns Day One Biopharmaceuticals (DAWN)?
According to the latest TipRanks data, approximately 0.14% of the company's stock is held by institutional investors, 16.77% is held by insiders, and 49.40% is held by retail investors.
    What percentage of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.14% of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors.
      What percentage of Day One Biopharmaceuticals (DAWN) stock is held by retail investors?
      According to the latest TipRanks data, approximately 49.40% of Day One Biopharmaceuticals (DAWN) stock is held by retail investors.
        Who owns the most shares of Day One Biopharmaceuticals (DAWN)?
        AI Day1 LLC owns the most shares of Day One Biopharmaceuticals (DAWN).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis